Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
US10744084B2 · kind B2 · utility
0Cited by
10References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 9, 2018 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Nov 9, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18733
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.